Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Rheumatology and Therapy|February 12, 2019
Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label StudyAndrew I Spitzer, John C Richmond, Virginia B Kraus, et al.
Annals of the Rheumatic Diseases|December 16, 2016
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trialsCharles Peterfy, Vibeke Strand, Lu Tian, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI ScorePhilip Conaghan, Marissa Lassere, Mikkel Østergaard, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring systemMikkel Østergaard, Charles Peterfy, Philip Conaghan, et al.
Arthritis and Rheumatism|March 31, 2007
Full-limb and knee radiography assessments of varus-valgus alignment and their relationship to osteoarthritis disease features by magnetic resonance imagingSakeba N Issa, Dorothy Dunlop, Alison Chang, et al.
Arthritis Research & Therapy|March 17, 2021
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritisKathleen Weisel, Scott Berger, Katie Thorn, et al.
Plos One|December 14, 2017
Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoringChan Beals, Richard Baumgartner, Charles Peterfy, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis MRI Studies ModuleCharles Peterfy, John Edmonds, Marissa Lassere, et al.
Rheumatology (Oxford, England)|December 29, 2016
Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging studyMaya H Buch, Elizabeth M A Hensor, Chadi Rakieh, et al.
Annals of the Rheumatic Diseases|October 31, 2014
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE studyCharles Peterfy, Paul Emery, Paul P Tak, et al.
Pageof 8